F16L (p.Phe16Leu) variant of UGT2B7 (UDP-glucuronosyltransferase 2B7)
F16L (p.Phe16Leu) in UGT2B7 (UDP-glucuronosyltransferase 2B7) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; high impact. The record also includes variant effect predictions and structural context.
F16L (p.Phe16Leu) variant details
- p.Phe16Leu
- Ensembl rs1560508238
- NCI-TCGA TCGA novel
- Variant assessed as somatic; high impact.
- Missense
- MetaLR 0.07
- MetaSVM -1.04
- SIFT 0.12
- UniProt: Variant assessed as somatic; high impact.
- Structural context available